Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Open Access

Correction

Correction: Low level of plasma DNase is associated with worse clinical outcome in testicular germ cell tumor patients and exogeneous DNase I improves cisplatin treatment efficacy

  • Michal Mego,
  • Barbora Vlkova,
  • Katarina Kalavska,
  • Michal Pastorek,
  • Zuzana Cierna,
  • Zuzana Sestakova,
  • Miroslav Chovanec,
  • Natalia Udvorkova,
  • Lucia Kucerova,
  • Peter Celec

The word “(Leverages)” should not be included in the article title. The correct title is: Low level of plasma DNase is associated with worse clinical outcome in testicular germ cell tumor patients and exogeneous DNase I improves cisplatin treatment efficacy.

Additionally, the author initials appear incorrectly in the citation. The correct citation is: Mego M, Vlkova B, Kalavska K, Pastorek M, Cierna Z, Sestakova Z, et al. (2025) Low level of plasma DNase is associated with worse clinical outcome in testicular germ cell tumor patients and exogeneous DNase I improves cisplatin treatment efficacy. PLoS One 20(12): e0336190. https://doi.org/10.1371/journal.pone.0336190.

Reference

  1. 1. Michal M, Barbora V, Katarina K, Michal P, Zuzana C, Zuzana S, et al. Low level of plasma DNase is associated with worse clinical outcome in testicular germ cell tumor patients and exogeneous DNase I improves (Leverages) cisplatin treatment efficacy. PLoS One. 2025;20(12):e0336190. pmid:41343562

Citation: Mego M, Vlkova B, Kalavska K, Pastorek M, Cierna Z, Sestakova Z, et al. (2025) Correction: Low level of plasma DNase is associated with worse clinical outcome in testicular germ cell tumor patients and exogeneous DNase I improves cisplatin treatment efficacy. PLoS One 20(12): e0340033. https://doi.org/10.1371/journal.pone.0340033

Published: December 31, 2025

Copyright: © 2025 Mego et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.